{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/dermatitis-contact/management/management/","result":{"pageContext":{"chapter":{"id":"967abec8-0583-54dd-9057-729d94203d4a","slug":"management","fullItemName":"Scenario: Management","depth":2,"htmlHeader":"<!-- begin field a5f41c01-03ba-4e73-aff5-3af0b389e8a9 --><h2>Scenario: Management of contact dermatitis</h2><!-- end field a5f41c01-03ba-4e73-aff5-3af0b389e8a9 -->","summary":"Covers the assessment and management of a person with contact dermatitis, and includes advice on how to prevent further episodes.","htmlStringContent":"<!-- begin item 6f70728e-da58-416b-abad-6c926529e98f --><!-- begin field c595896a-dcbe-4648-899b-acbc01592a3e --><p>From age 1 month onwards.</p><!-- end field c595896a-dcbe-4648-899b-acbc01592a3e --><!-- end item 6f70728e-da58-416b-abad-6c926529e98f -->","topic":{"id":"a372c7ca-356b-58f9-8c90-6f20d1b6df4b","topicId":"ed82aa3c-29ae-494e-a0d6-a1e528deec8e","topicName":"Dermatitis - contact","slug":"dermatitis-contact","lastRevised":"Last revised in July 2018","chapters":[{"id":"48fd5a64-f64e-56bd-b7ce-e8dc52b4a027","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"1d441ed9-c274-5d97-b56e-1e9a3504cb01","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"576c42e8-ca4a-52da-9d9b-b1f965d09f96","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"300b61dc-b3e8-5afe-b580-9ead2010c3bf","slug":"changes","fullItemName":"Changes"},{"id":"6887aa92-a914-56d0-9649-e4ce4ed5a18d","slug":"update","fullItemName":"Update"}]},{"id":"d415662e-0bb8-5b15-aa77-16dff0459757","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"c307fc12-d5cc-5b4f-9ba5-9b480edf8508","slug":"goals","fullItemName":"Goals"},{"id":"6b9b972a-9875-5415-9fa8-1d8f5510b461","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"52fbf861-c880-5dff-b79f-0ca82a56019c","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"a22521b0-bb27-5325-91dc-7daa066c1b1d","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"7f923d5d-b71c-5db5-8299-9210a1f1d886","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"79e923f4-f50f-5120-8234-9ed545c3a161","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"a6a71aac-99e2-520c-a20f-e25220f33747","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"2f338dbd-721c-5ebc-8907-6b027acc82e5","slug":"definition","fullItemName":"Definition"},{"id":"32cc4e93-9611-54f1-aea5-e6d6b6953f22","slug":"common-allergens-irritants","fullItemName":"Common allergens and irritants"},{"id":"58bb10ab-6b3f-5ecc-ac8c-6f681ff46929","slug":"prevalence","fullItemName":"Prevalence"},{"id":"20aa4b76-1d89-5bde-a35e-150d06e45bf7","slug":"prognosis","fullItemName":"Prognosis"},{"id":"de87f829-cee5-5018-81b9-954d2fcbaba6","slug":"complications","fullItemName":"Complications"}]},{"id":"6428a179-6595-5322-b747-f39c86c9f935","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"c89b63e2-bdab-55f9-9a06-ddfe8c885e66","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"4e6e6ead-fb0c-50dc-8f00-97ee38199b1c","slug":"assessment","fullItemName":"Assessment"},{"id":"50b9b76a-77d8-5636-a601-a1b6855dd3ef","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"33735cf8-dd3d-561b-b6a7-290db6ea3894","fullItemName":"Management","slug":"management","subChapters":[{"id":"967abec8-0583-54dd-9057-729d94203d4a","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"f8442950-075a-5e27-83f9-2373f22d9f84","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"0c0d3a42-2c8c-54cf-8287-105b32bf89ae","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"444a0d43-1d3f-53e0-ba7f-559084e6feda","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"b2ba7d2b-3701-5afc-98b3-8cbb4fb64c98","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"3351c89a-ce2a-5e1f-ab7b-6bbc9e3582d6","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"db447477-9e41-5a3f-9189-9b562749d350","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"43948add-1750-5d08-a07e-8cb1ee7a4038","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"fa8ab263-4add-5697-9185-a3fc27b697c8","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"33735cf8-dd3d-561b-b6a7-290db6ea3894","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"d4e5a2ef-e191-53e0-a12b-9f8cd1fba858","slug":"management-in-primary-care","fullItemName":"Management in primary care","depth":3,"htmlHeader":"<!-- begin field 7b75d201-47b6-49fd-866a-e18c9421193b --><h3>How should I manage a person with contact dermatitis in primary care?</h3><!-- end field 7b75d201-47b6-49fd-866a-e18c9421193b -->","summary":null,"htmlStringContent":"<!-- begin item 68309c7b-90af-4444-86e1-5c653a8cb378 --><!-- begin field 86b2a7c6-f53e-40dd-9017-721b6adfa159 --><ul><li><strong>If a causative agent has been identified:</strong><ul><li>Advise the person that avoidance of the stimulus is the most important element of treatment and prevention of recurrent episodes of contact dermatitis.<ul><li>Eight to twelve weeks of avoidance may be needed before clinical improvement is seen — in some cases contact dermatitis may persist and require long term treatment.</li><li>Avoidance may be difficult, especially with common allergens which have multiple potential sources of exposure.</li></ul></li><li>Advise the use of liberal emollient and soap substitutes to maintain skin hydration and improve barrier repair.<ul><li>Advise the person that they must not smoke, use naked flames (or be near people who are smoking or using naked flames), or go near anything that may cause a fire while emollients are in contact with dressings, clothing or bedding.</li><li>Do not prescribe aqueous cream as it is thought to cause a disproportionate amount of skin reactions.</li></ul></li><li>Consider the need for topical corticosteroids:<ul><li>Topical steroids may be required to control symptoms — choice of topical corticosteroid depends on the specific clinical situation including the age of the person and severity, location and extent of dermatitis.</li><li>For further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/corticosteroids-topical-skin-nose-eyes/\">Corticosteroids - topical (skin), nose, and eyes</a>.</li></ul></li></ul></li><li><strong>If secondary infection of the skin is suspected, treat appropriately:</strong><ul><li>For further information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/impetigo/\">Impetigo</a> and <a class=\"topic-reference external-reference\" href=\"/topics/cellulitis-acute/\">Cellulitis - acute</a>.</li></ul></li><li><strong>If complete avoidance of the stimulus is not possible, advise the person:</strong><ul><li>On measures to prevent or minimise contact with affected areas of skin, for example:<ul><li>Rinsing with water or washing with soap or, preferably, a soap substitute as soon as possible after contact (overuse of skin-cleaning agents can aggravate contact dermatitis).</li><li>Substituting products that contain identified allergens or irritants with other products that do not contain them.</li><li>Use of gloves (cotton-lined rubber or plastic) for handling potential irritants — certain chemicals may require heavier duty protective materials. Gloves should be removed frequently, as sweating may aggravate existing dermatitis.</li><li>Avoidance of accumulation of chemicals and water underneath jewellery.</li></ul></li></ul></li><li><strong>Consider referral to dermatology if:</strong><ul><li>Dermatitis (in particular hand and facial dermatitis) is severe, chronic, recurring or persistent.</li><li>Previously stable dermatitis has become difficult or impossible to control with standard treatments.</li><li>Allergy to prescribed or over-the-counter topical treatments is suspected.</li><li>Suspected contact dermatitis does not respond to treatment in primary care, has atypical features (<a class=\"topic-reference internal-reference\" href=\"/topics/dermatitis-contact/diagnosis/differential-diagnosis/\">other diagnoses</a> should be considered) or the diagnosis is unclear.</li><li>Contact dermatitis is thought to be associated with occupation.</li></ul></li><li><strong>If contact dermatitis is confirmed to be associated with occupation:</strong><ul><li>The employer is legally obliged to assess health risks at work and prevent (or if this is not reasonably practicable) adequately control exposure to hazards (for example by change of duties or suitable personal protective measures).</li><li>The employer has a legal duty to report a case of the disease to the Health and Safety Executive (HSE).</li><li>Further information on <a data-hyperlink-id=\"a478a8fb-e21c-40b1-b68c-a92d012761e8\" href=\"http://www.hse.gov.uk/skin/employ/prevention.htm\" target=\"_blank\">work-related skin problems</a> is available on the <a data-hyperlink-id=\"d2077466-3d86-435a-b479-a92d01276233\" href=\"http://www.hse.gov.uk/\" target=\"_blank\">Health and Safety Executive website</a>.</li></ul></li><li><strong>Patient information on contact dermatitis is available from:</strong><ul><li>NHS A-Z — ‘<a data-hyperlink-id=\"b039978e-0000-4bb9-a847-a92d01276238\" href=\"https://www.nhs.uk/conditions/contact-dermatitis/\" target=\"_blank\">Contact dermatitis</a>’.</li><li>British Association of Dermatologists — '<a data-hyperlink-id=\"852384bf-1d52-4205-8496-a92d0127624b\" href=\"http://www.bad.org.uk/for-the-public/patient-information-leaflets\" target=\"_blank\">Contact Dermatitis</a>' and ‘<a data-hyperlink-id=\"864467a0-f352-409d-b50e-a92d012763a8\" href=\"http://www.bad.org.uk/for-the-public/patient-information-leaflets\" target=\"_blank\">Hand Dermatitis - How to care for your hands</a>'.</li></ul></li></ul><!-- end field 86b2a7c6-f53e-40dd-9017-721b6adfa159 --><!-- end item 68309c7b-90af-4444-86e1-5c653a8cb378 -->","subChapters":[{"id":"87586797-601c-5a97-83aa-34dceb6114a1","slug":"basis-for-recommendation-127","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field e173548f-69c7-4da4-8dae-254f341fadd1 --><h4>Basis for recommendation</h4><!-- end field e173548f-69c7-4da4-8dae-254f341fadd1 -->","summary":null,"htmlStringContent":"<!-- begin item 12735a19-775b-4def-a3cb-32be4d22ad06 --><!-- begin field b468aa90-c5b1-44f9-a446-77fe7068f6a9 --><p>The recommendations on the management of contact dermatitis are based on the clinical guidelines <em>U.K. standards of care for occupational contact dermatitis and occupational contact urticaria </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Adisesh, 2013</a>] , <em>Guideline: contact dermatitis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Brasch, 2014</a>], <em>Contact dermatitis: a practice parameter-update 2015</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Fonacier, 2015</a>], <em>European Society of Contact Dermatitis guideline for diagnostic patch testing – recommendations on best practice 2015</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Johansen, 2015</a>], <em>British Association of Dermatologists’ guidelines for the management of contact dermatitis 2017</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">BAD, 2017</a>], and <em>Eczema: contact allergic dermatitis (including latex and rubber allergy)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">PCDS, 2018</a>], and expert opinion in Rook’s Textbook of Dermatology [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">White, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Wilkinson, 2016</a>] and review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Admani, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Fonacier, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Mowad, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Rashid, 2016</a>].</p><h5>Avoidance of causative agent</h5><ul><li>Identifying and eliminating exposure to potential stimuli is the most important step in the treatment of contact dermatitis. This recommendation is supported by expert opinion from clinical guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Fonacier, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">HSE, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Alfonso, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">BAD, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">PCDS, 2018</a>], a dermatology textbook [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">White, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Wilkinson, 2016</a>] and review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Admani, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Tan, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Pigatto, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Rashid, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Mostosi, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Fonacier, 2018</a>].</li><li>The expected timing of clinical improvement following avoidance is based on expert opinion in review articles:<ul><li>Chronic contact dermatitis may take 8-12 weeks of avoidance before clinical improvement is seen [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Admani, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Pigatto, 2015</a>].</li><li>In some cases, despite treatment, contact dermatitis may persist and require long term management [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Rashid, 2016</a>].</li></ul></li></ul><h5>Emollients and barrier repair</h5><ul><li>Expert opinion in guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Adisesh, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Brasch, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">BAD, 2017</a>], a dermatology textbook [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">White, 2016</a>] and review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Admani, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Tan, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Pigatto, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Mostosi, 2016</a>] is that barrier creams and emollients may be useful in treatment and prevention of contact dermatitis by helping maintain the functional integrity of skin — good quality evidence is lacking.</li><li>A Cochrane review of interventions for prevention of occupational irritant hand dermatitis (n=999, 4 studies) found that 29% of people who applied barrier creams developed skin irritation compared to 33% of controls who did not (risk ratio 0.87, 95% CI 0.72 to 1.06). In addition, analysis of data from three studies (n=507) showed that 13% of people who used moisturisers developed hand skin irritations, compared to 19% of those who did not use moisturisers (RR 0.71, 95% CI 0.46 to 1.09) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Bauer, 2018</a>].</li><li>Aqueous cream is generally not recommended because of the high risk of developing skin reactions — the Medicines and Healthcare products Regulatory Agency (MHRA) warns that aqueous cream may cause local skin reactions, such as stinging, burning, itching, and redness, when it is used as a leave-on emollient, especially in children with atopic eczema. The reactions, which are not generally serious, often occur within 20 minutes of application but can occur later, and may be due to sodium lauryl sulfate or other additives [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">MHRA, 2013</a>].</li></ul><h5>Topical corticosteroids</h5><ul><li>Symptomatic treatment of contact dermatitis with topical corticosteroids is common in practice.<ul><li>The efficacy of topical corticosteroids in treatment of allergic contact dermatitis is well documented but few studies have evaluated effectiveness in irritant contact dermatitis and available evidence is conflicting [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Brasch, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Rashid, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">White, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">BMJ Best Practice, 2017</a>].</li><li>Expert opinion in a dermatology textbook [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">White, 2016</a>] is that because it is often difficult to distinguish clinically between allergic and irritant contact dermatitis, topical corticosteroids are recommended for the treatment of irritant contact dermatitis.</li></ul></li></ul><h5>Referral to dermatology</h5><ul><li>The recommendations on when to consider referral to dermatology are based on clinical guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Brasch, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">BAD, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">PCDS, 2018</a>] and expert opinion in a dermatology textbook [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">White, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Wilkinson, 2016</a>] and review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Fonacier, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Mowad, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Rashid, 2016</a>].</li><li>The British Association of Dermatology [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">BAD, 2017</a>] recommend that patch testing be offered to people with:<ul><li>Chronic or persistent dermatitis (in particular with hand and facial dermatitis) as clinical features alone are unreliable in distinguishing allergic, irritant and endogenous dermatitis</li><li>Previously well controlled atopic/endogenous dermatitis which has become difficult or impossible to control with the same topical treatments.</li></ul></li><li>The Primary Care Dermatological Society [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">PCDS, 2018</a>]  recommend referral to dermatology if contact dermatitis may be due topical treatments such as neomycin or corticosteroids (such as hydrocortisone).</li><li>Expert opinion in a review article is that although empirical avoidance of a suspected allergen may improve contact dermatitis, identification of the specific allergen by patch testing increases adherence and options and improves outcome [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dermatitis-contact/references/\">Fonacier, 2018</a>].</li></ul><!-- end field b468aa90-c5b1-44f9-a446-77fe7068f6a9 --><!-- end item 12735a19-775b-4def-a3cb-32be4d22ad06 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}